FindTrial
Sign In

Mutation study in Covid-19

A retrospective, non-randomized observational study to detect SARS CoV-19 Delta variants by RT-PCR method in the positive samples archived in the Lab

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/10/037034
Enrollment
100
Registered
2021-10-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: U07-U07- Provisional assignment of new diseases of uncertain etiology or emergency use

Interventions

Control Intervention1: NA: NA Control Intervention2: NIL: NIL

Sponsors

Cancyte Technologies Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the Covid-19 positive samples collected at Cancyte for the period of Jan 2021-July 2021

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
Detecting presence of Covid-19 delta variants by RT-PCR in the samples collected by Nasopharyngeal and Oropharyngeal swabs preserved at our library.Timepoint: 01 week—

Secondary

MeasureTime frame
Establishing a rapid and reliable detection of the delta mutants in an ICMR approved PCR labsTimepoint: 01 Week—

Countries

India

Contacts

Public ContactSudarson Sundarrajan

CANCYTE TECHNOLOGIES PRIVATE LIMITED

sudarson@cancyte.com9738539775

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026